Intelligent Bio Solutions Inc. (INBS) filed a Current Report on Form 8-K with the Securities and Exchange Commission on October 12, 2026, announcing the adoption of the Second Amended and Restated Bylaws. The amendment, which became effective immediately upon adoption, was approved by the Company's Board of Directors.
The primary update involves a revision to Section 2.6 of the bylaws. The Company clarified the voting requirements for matters brought before stockholder meetings. Specifically, the amendment states that any matter other than the election of directors will be decided by the affirmative vote of the holders of a majority in voting power of the votes cast. The text further specifies that abstentions will be excluded from the count and will have no impact on the vote held on such matters.
The filing also references Exhibit 99.1, which is a presentation regarding the Company's business and operations. This presentation was made available to investors on October 13, 2026, and can be accessed through the Investors section of the Company's website at www.ibs.inc.
